APA (7th ed.) Citation

Belmonte, C., Ochoa, D., Román, M., Saiz‐Rodríguez, M., Wojnicz, A., Gómez‐Sánchez, C. I., . . . Abad‐Santos, F. (2018). Influence of <italic>CYP2D6</italic>,<italic> CYP3A4</italic>,<italic> CYP3A5</italic> and <italic>ABCB1</italic> Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers. Basic & Clinical Pharmacology & Toxicology, 122(6), 596. https://doi.org/10.1111/bcpt.12960

Chicago Style (17th ed.) Citation

Belmonte, Carmen, Dolores Ochoa, Manuel Román, Miriam Saiz‐Rodríguez, Aneta Wojnicz, Clara Isabel Gómez‐Sánchez, Samuel Martín‐Vílchez, and Francisco Abad‐Santos. "Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers." Basic & Clinical Pharmacology & Toxicology 122, no. 6 (2018): 596. https://doi.org/10.1111/bcpt.12960.

MLA (9th ed.) Citation

Belmonte, Carmen, et al. "Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers." Basic & Clinical Pharmacology & Toxicology, vol. 122, no. 6, 2018, p. 596, https://doi.org/10.1111/bcpt.12960.